International consensus statement on allergy and rhinology: rhinosinusitis 2021
RR Orlandi, TT Kingdom, TL Smith… - International forum of …, 2021 - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …
Chronic rhinosinusitis with nasal polyps
WW Stevens, RP Schleimer, RC Kern - The journal of allergy and clinical …, 2016 - Elsevier
Chronic rhinosinusitis with nasal polyps (CRSwNP) is an important clinical entity diagnosed
by the presence of both subjective and objective evidence of chronic sinonasal …
by the presence of both subjective and objective evidence of chronic sinonasal …
Clinical practice guideline (update): adult sinusitis
RM Rosenfeld, JF Piccirillo… - … –Head and Neck …, 2015 - journals.sagepub.com
Objective This update of a 2007 guideline from the American Academy of Otolaryngology—
Head and Neck Surgery Foundation provides evidence-based recommendations to manage …
Head and Neck Surgery Foundation provides evidence-based recommendations to manage …
Endoscopic sinus surgery for type‐2 CRS wNP: an endotype‐based retrospective study
S Alsharif, K Jonstam, T Van Zele, P Gevaert… - The …, 2019 - Wiley Online Library
Objectives Nasal polyps are often characterized by type 2 inflammation and disease
recurrence. We developed a new surgical technique, referred to as reboot approach, which …
recurrence. We developed a new surgical technique, referred to as reboot approach, which …
[HTML][HTML] Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
Background Chronic rhinosinusitis with nasal polyps (CRSwNP) and type 2 asthma share
the same inflammatory pathophysiology and are frequent comorbidities. Dupilumab, a fully …
the same inflammatory pathophysiology and are frequent comorbidities. Dupilumab, a fully …
Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis
S Chen, A Zhou, B Emmanuel, K Thomas… - … Medical Research and …, 2020 - Taylor & Francis
Objectives We conducted a systematic literature review (SLR) to determine the
epidemiology and clinical burden of chronic rhinosinusitis with nasal polyps (CRSwNP) and …
epidemiology and clinical burden of chronic rhinosinusitis with nasal polyps (CRSwNP) and …
Medical therapies for adult chronic sinusitis: a systematic review
L Rudmik, ZM Soler - Jama, 2015 - jamanetwork.com
Importance Chronic sinusitis is a common inflammatory condition defined by persistent
symptomatic inflammation of the sinonasal cavities lasting longer than 3 months. It accounts …
symptomatic inflammation of the sinonasal cavities lasting longer than 3 months. It accounts …
[HTML][HTML] Comprehensive review on endonasal endoscopic sinus surgery
RK Weber, W Hosemann - GMS current topics in …, 2015 - ncbi.nlm.nih.gov
Endonasal endoscopic sinus surgery is the standard procedure for surgery of most
paranasal sinus diseases. Appropriate frame conditions provided, the respective procedures …
paranasal sinus diseases. Appropriate frame conditions provided, the respective procedures …
Short-term efficacy and safety of oral and nasal corticosteroids in COVID-19 patients with olfactory dysfunction: a European multicenter study
Background: The objective of this study was to investigate the efficacy and safety of early
administration of oral corticosteroids (OC) or nasal corticosteroids (NC) as an add-on to …
administration of oral corticosteroids (OC) or nasal corticosteroids (NC) as an add-on to …
Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities
Inflammation that is not resolved in due course becomes a chronic disease. The treatment of
chronic inflammatory diseases involves a long-term use of anti-inflammatory drugs such as …
chronic inflammatory diseases involves a long-term use of anti-inflammatory drugs such as …